Pharmaceutical Candidates

Discovery
Preclinical
Clinical

CDX-101

Astaxanthin Rx Candidate for Severe Hypertriglyceridemia

Preclinical

50%

CDX-301

Zeaxanthin Rx Candidate for Stargardt Disease

Preclinical

43%

Dietary Supplements

Development
Launch
Marketing

ZanthoSyn®

Astaxanthin Supplement for Inflammatory Health

Commercially Available Dietary Supplement

85%